Pharmacy and Medicine Stevenage, England, United Kingdom
Connect with the speaker?
Dr. Prinjha currently leads GSK's Epinova Epigenetics DPU and is co-chair of the GSK Biology Council and GSK’s observer of the Board of Padlock Therapeutics. Prior to leading this DPU he led the Target Progression department with responsibilities for target selection, validation and epigenetic compound characterization along with coordinating academic collaborations that have resulted in a growing number of ground-breaking high-impact publications that he will discuss.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)